nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—CTSK—osteoporosis	0.591	1	CbGaD
Telaprevir—ALB—Estropipate—osteoporosis	0.0529	0.253	CbGbCtD
Telaprevir—ALB—Estradiol—osteoporosis	0.022	0.105	CbGbCtD
Telaprevir—ABCB1—Ethinyl Estradiol—osteoporosis	0.0178	0.0854	CbGbCtD
Telaprevir—CYP3A4—Calcitriol—osteoporosis	0.0166	0.0794	CbGbCtD
Telaprevir—CYP3A4—Estropipate—osteoporosis	0.0166	0.0794	CbGbCtD
Telaprevir—CYP3A4—Ergocalciferol—osteoporosis	0.0133	0.0635	CbGbCtD
Telaprevir—ABCB1—Conjugated Estrogens—osteoporosis	0.0131	0.0627	CbGbCtD
Telaprevir—ABCB1—Estradiol—osteoporosis	0.0115	0.0551	CbGbCtD
Telaprevir—CYP3A4—Raloxifene—osteoporosis	0.0111	0.053	CbGbCtD
Telaprevir—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0107	0.0512	CbGbCtD
Telaprevir—CTSK—periosteum—osteoporosis	0.00988	0.332	CbGeAlD
Telaprevir—CYP3A4—Cholecalciferol—osteoporosis	0.00854	0.0409	CbGbCtD
Telaprevir—CTSK—skull—osteoporosis	0.00812	0.273	CbGeAlD
Telaprevir—CYP3A4—Conjugated Estrogens—osteoporosis	0.00784	0.0376	CbGbCtD
Telaprevir—CYP3A4—Estradiol—osteoporosis	0.00688	0.033	CbGbCtD
Telaprevir—Boceprevir—CTSK—osteoporosis	0.00552	1	CrCbGaD
Telaprevir—ORM1—vertebral column—osteoporosis	0.00428	0.144	CbGeAlD
Telaprevir—CMA1—bone marrow—osteoporosis	0.00178	0.0599	CbGeAlD
Telaprevir—CTSK—uterus—osteoporosis	0.00135	0.0454	CbGeAlD
Telaprevir—CTSK—Estradiol—Estropipate—osteoporosis	0.00126	0.418	CbGdCrCtD
Telaprevir—CTSS—uterus—osteoporosis	0.00118	0.0398	CbGeAlD
Telaprevir—CTSK—bone marrow—osteoporosis	0.00115	0.0386	CbGeAlD
Telaprevir—CTSS—bone marrow—osteoporosis	0.001	0.0338	CbGeAlD
Telaprevir—CTSK—Estradiol—Conjugated Estrogens—osteoporosis	0.000954	0.317	CbGdCrCtD
Telaprevir—CTSK—Estradiol—Ethinyl Estradiol—osteoporosis	0.000801	0.266	CbGdCrCtD
Telaprevir—ORM1—bone marrow—osteoporosis	0.0006	0.0202	CbGeAlD
Telaprevir—Blood creatinine increased—Zoledronate—osteoporosis	0.000365	0.00419	CcSEcCtD
Telaprevir—Infestation—Ethinyl Estradiol—osteoporosis	0.000355	0.00407	CcSEcCtD
Telaprevir—Infestation NOS—Ethinyl Estradiol—osteoporosis	0.000355	0.00407	CcSEcCtD
Telaprevir—Hypokalaemia—Zoledronate—osteoporosis	0.000355	0.00407	CcSEcCtD
Telaprevir—Asthenia—Calcium Acetate—osteoporosis	0.000353	0.00404	CcSEcCtD
Telaprevir—Eye disorder—Ibandronate—osteoporosis	0.000352	0.00404	CcSEcCtD
Telaprevir—Blood creatinine increased—Conjugated Estrogens—osteoporosis	0.000351	0.00403	CcSEcCtD
Telaprevir—Erythema multiforme—Calcitriol—osteoporosis	0.000349	0.004	CcSEcCtD
Telaprevir—Pruritus—Calcium Acetate—osteoporosis	0.000348	0.00399	CcSEcCtD
Telaprevir—Infestation NOS—Risedronate—osteoporosis	0.000346	0.00396	CcSEcCtD
Telaprevir—Infestation—Risedronate—osteoporosis	0.000346	0.00396	CcSEcCtD
Telaprevir—Malnutrition—Estropipate—osteoporosis	0.000342	0.00392	CcSEcCtD
Telaprevir—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.000341	0.00392	CcSEcCtD
Telaprevir—Diarrhoea—Calcium Acetate—osteoporosis	0.000336	0.00385	CcSEcCtD
Telaprevir—Eczema—Estradiol—osteoporosis	0.000334	0.00383	CcSEcCtD
Telaprevir—Dysgeusia—Alendronate—osteoporosis	0.00033	0.00378	CcSEcCtD
Telaprevir—Infestation NOS—Pamidronate—osteoporosis	0.000329	0.00377	CcSEcCtD
Telaprevir—Infestation—Pamidronate—osteoporosis	0.000329	0.00377	CcSEcCtD
Telaprevir—Malnutrition—Ibandronate—osteoporosis	0.000328	0.00376	CcSEcCtD
Telaprevir—Hepatobiliary disease—Risedronate—osteoporosis	0.000327	0.00375	CcSEcCtD
Telaprevir—Dizziness—Calcium Acetate—osteoporosis	0.000325	0.00373	CcSEcCtD
Telaprevir—Dysgeusia—Ibandronate—osteoporosis	0.000321	0.00368	CcSEcCtD
Telaprevir—Infection—Etidronic acid—osteoporosis	0.00032	0.00367	CcSEcCtD
Telaprevir—Urinary tract disorder—Ethinyl Estradiol—osteoporosis	0.000314	0.00361	CcSEcCtD
Telaprevir—Dysgeusia—Calcitriol—osteoporosis	0.000314	0.0036	CcSEcCtD
Telaprevir—Vomiting—Calcium Acetate—osteoporosis	0.000312	0.00358	CcSEcCtD
Telaprevir—Urethral disorder—Ethinyl Estradiol—osteoporosis	0.000312	0.00358	CcSEcCtD
Telaprevir—Asthenia—Ergocalciferol—osteoporosis	0.000311	0.00357	CcSEcCtD
Telaprevir—Anaemia—Alendronate—osteoporosis	0.000311	0.00357	CcSEcCtD
Telaprevir—Urinary tract disorder—Risedronate—osteoporosis	0.000307	0.00352	CcSEcCtD
Telaprevir—Oedema peripheral—Risedronate—osteoporosis	0.000306	0.00351	CcSEcCtD
Telaprevir—Urethral disorder—Risedronate—osteoporosis	0.000304	0.00349	CcSEcCtD
Telaprevir—Anaemia—Ibandronate—osteoporosis	0.000303	0.00348	CcSEcCtD
Telaprevir—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.000301	0.00345	CcSEcCtD
Telaprevir—Infestation NOS—Zoledronate—osteoporosis	0.0003	0.00344	CcSEcCtD
Telaprevir—Infestation—Zoledronate—osteoporosis	0.0003	0.00344	CcSEcCtD
Telaprevir—Eye disorder—Ethinyl Estradiol—osteoporosis	0.000298	0.00341	CcSEcCtD
Telaprevir—Syncope—Raloxifene—osteoporosis	0.000297	0.00341	CcSEcCtD
Telaprevir—Nausea—Calcium Acetate—osteoporosis	0.000292	0.00335	CcSEcCtD
Telaprevir—Urinary tract disorder—Pamidronate—osteoporosis	0.000291	0.00334	CcSEcCtD
Telaprevir—Loss of consciousness—Raloxifene—osteoporosis	0.000291	0.00334	CcSEcCtD
Telaprevir—Eye disorder—Risedronate—osteoporosis	0.00029	0.00333	CcSEcCtD
Telaprevir—Urethral disorder—Pamidronate—osteoporosis	0.000289	0.00332	CcSEcCtD
Telaprevir—Infestation NOS—Conjugated Estrogens—osteoporosis	0.000289	0.00332	CcSEcCtD
Telaprevir—Infestation—Conjugated Estrogens—osteoporosis	0.000289	0.00332	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000289	0.00331	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00028	0.00321	CcSEcCtD
Telaprevir—Infection—Estropipate—osteoporosis	0.000277	0.00318	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000277	0.00318	CcSEcCtD
Telaprevir—Malnutrition—Ethinyl Estradiol—osteoporosis	0.000277	0.00318	CcSEcCtD
Telaprevir—Eye disorder—Pamidronate—osteoporosis	0.000276	0.00316	CcSEcCtD
Telaprevir—Nervous system disorder—Estropipate—osteoporosis	0.000274	0.00314	CcSEcCtD
Telaprevir—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.000273	0.00314	CcSEcCtD
Telaprevir—Infection—Alendronate—osteoporosis	0.000273	0.00313	CcSEcCtD
Telaprevir—Skin disorder—Estropipate—osteoporosis	0.000271	0.00311	CcSEcCtD
Telaprevir—Malnutrition—Risedronate—osteoporosis	0.00027	0.0031	CcSEcCtD
Telaprevir—Infection—Raloxifene—osteoporosis	0.000269	0.00308	CcSEcCtD
Telaprevir—Urinary tract disorder—Zoledronate—osteoporosis	0.000266	0.00305	CcSEcCtD
Telaprevir—Shock—Raloxifene—osteoporosis	0.000266	0.00305	CcSEcCtD
Telaprevir—Infection—Ibandronate—osteoporosis	0.000266	0.00305	CcSEcCtD
Telaprevir—Oedema peripheral—Zoledronate—osteoporosis	0.000266	0.00304	CcSEcCtD
Telaprevir—Nervous system disorder—Raloxifene—osteoporosis	0.000265	0.00304	CcSEcCtD
Telaprevir—Thrombocytopenia—Raloxifene—osteoporosis	0.000265	0.00303	CcSEcCtD
Telaprevir—Urethral disorder—Zoledronate—osteoporosis	0.000264	0.00303	CcSEcCtD
Telaprevir—Shock—Ibandronate—osteoporosis	0.000263	0.00302	CcSEcCtD
Telaprevir—Skin disorder—Raloxifene—osteoporosis	0.000263	0.00301	CcSEcCtD
Telaprevir—Nervous system disorder—Ibandronate—osteoporosis	0.000262	0.00301	CcSEcCtD
Telaprevir—Skin disorder—Ibandronate—osteoporosis	0.00026	0.00298	CcSEcCtD
Telaprevir—Nausea—Ergocalciferol—osteoporosis	0.000258	0.00296	CcSEcCtD
Telaprevir—Malnutrition—Pamidronate—osteoporosis	0.000257	0.00295	CcSEcCtD
Telaprevir—Urticaria—Etidronic acid—osteoporosis	0.000256	0.00294	CcSEcCtD
Telaprevir—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.000256	0.00293	CcSEcCtD
Telaprevir—Skin disorder—Calcitriol—osteoporosis	0.000254	0.00292	CcSEcCtD
Telaprevir—Eye disorder—Zoledronate—osteoporosis	0.000252	0.00289	CcSEcCtD
Telaprevir—Dysgeusia—Pamidronate—osteoporosis	0.000252	0.00288	CcSEcCtD
Telaprevir—Anaemia—Risedronate—osteoporosis	0.00025	0.00286	CcSEcCtD
Telaprevir—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000245	0.00281	CcSEcCtD
Telaprevir—Eye disorder—Conjugated Estrogens—osteoporosis	0.000243	0.00278	CcSEcCtD
Telaprevir—Syncope—Risedronate—osteoporosis	0.000242	0.00278	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Estropipate—osteoporosis	0.000241	0.00276	CcSEcCtD
Telaprevir—Fatigue—Estropipate—osteoporosis	0.000241	0.00276	CcSEcCtD
Telaprevir—Loss of consciousness—Risedronate—osteoporosis	0.000238	0.00272	CcSEcCtD
Telaprevir—Anaemia—Pamidronate—osteoporosis	0.000237	0.00272	CcSEcCtD
Telaprevir—Malnutrition—Zoledronate—osteoporosis	0.000235	0.00269	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000234	0.00269	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000233	0.00268	CcSEcCtD
Telaprevir—Infestation—Estradiol—osteoporosis	0.000231	0.00265	CcSEcCtD
Telaprevir—Infestation NOS—Estradiol—osteoporosis	0.000231	0.00265	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000231	0.00265	CcSEcCtD
Telaprevir—Fatigue—Ibandronate—osteoporosis	0.000231	0.00265	CcSEcCtD
Telaprevir—Syncope—Pamidronate—osteoporosis	0.00023	0.00264	CcSEcCtD
Telaprevir—Dysgeusia—Zoledronate—osteoporosis	0.00023	0.00263	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000228	0.00262	CcSEcCtD
Telaprevir—Pruritus—Etidronic acid—osteoporosis	0.000228	0.00262	CcSEcCtD
Telaprevir—Malnutrition—Conjugated Estrogens—osteoporosis	0.000226	0.00259	CcSEcCtD
Telaprevir—Loss of consciousness—Pamidronate—osteoporosis	0.000226	0.00259	CcSEcCtD
Telaprevir—Infection—Ethinyl Estradiol—osteoporosis	0.000225	0.00258	CcSEcCtD
Telaprevir—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000222	0.00254	CcSEcCtD
Telaprevir—Urticaria—Estropipate—osteoporosis	0.000222	0.00254	CcSEcCtD
Telaprevir—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000221	0.00254	CcSEcCtD
Telaprevir—Diarrhoea—Etidronic acid—osteoporosis	0.000221	0.00253	CcSEcCtD
Telaprevir—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00022	0.00252	CcSEcCtD
Telaprevir—Infection—Risedronate—osteoporosis	0.000219	0.00251	CcSEcCtD
Telaprevir—Hepatobiliary disease—Estradiol—osteoporosis	0.000219	0.00251	CcSEcCtD
Telaprevir—Urticaria—Alendronate—osteoporosis	0.000218	0.0025	CcSEcCtD
Telaprevir—Shock—Risedronate—osteoporosis	0.000217	0.00249	CcSEcCtD
Telaprevir—Anaemia—Zoledronate—osteoporosis	0.000217	0.00249	CcSEcCtD
Telaprevir—Nervous system disorder—Risedronate—osteoporosis	0.000216	0.00248	CcSEcCtD
Telaprevir—Skin disorder—Risedronate—osteoporosis	0.000214	0.00246	CcSEcCtD
Telaprevir—Urticaria—Ibandronate—osteoporosis	0.000213	0.00244	CcSEcCtD
Telaprevir—Syncope—Zoledronate—osteoporosis	0.00021	0.00241	CcSEcCtD
Telaprevir—ABCB1—uterus—osteoporosis	0.000209	0.00702	CbGeAlD
Telaprevir—Infection—Pamidronate—osteoporosis	0.000208	0.00239	CcSEcCtD
Telaprevir—Urticaria—Calcitriol—osteoporosis	0.000208	0.00239	CcSEcCtD
Telaprevir—Shock—Pamidronate—osteoporosis	0.000206	0.00237	CcSEcCtD
Telaprevir—Loss of consciousness—Zoledronate—osteoporosis	0.000206	0.00236	CcSEcCtD
Telaprevir—Nervous system disorder—Pamidronate—osteoporosis	0.000206	0.00236	CcSEcCtD
Telaprevir—Thrombocytopenia—Pamidronate—osteoporosis	0.000205	0.00235	CcSEcCtD
Telaprevir—Urinary tract disorder—Estradiol—osteoporosis	0.000205	0.00235	CcSEcCtD
Telaprevir—Vomiting—Etidronic acid—osteoporosis	0.000205	0.00235	CcSEcCtD
Telaprevir—Oedema peripheral—Estradiol—osteoporosis	0.000205	0.00235	CcSEcCtD
Telaprevir—Urethral disorder—Estradiol—osteoporosis	0.000204	0.00233	CcSEcCtD
Telaprevir—Rash—Etidronic acid—osteoporosis	0.000203	0.00233	CcSEcCtD
Telaprevir—Dermatitis—Etidronic acid—osteoporosis	0.000203	0.00233	CcSEcCtD
Telaprevir—Syncope—Conjugated Estrogens—osteoporosis	0.000203	0.00232	CcSEcCtD
Telaprevir—Asthenia—Estropipate—osteoporosis	0.0002	0.0023	CcSEcCtD
Telaprevir—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000199	0.00228	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000198	0.00227	CcSEcCtD
Telaprevir—Pruritus—Estropipate—osteoporosis	0.000197	0.00226	CcSEcCtD
Telaprevir—Asthenia—Alendronate—osteoporosis	0.000197	0.00226	CcSEcCtD
Telaprevir—Erythema multiforme—Estradiol—osteoporosis	0.000196	0.00225	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000195	0.00224	CcSEcCtD
Telaprevir—Fatigue—Ethinyl Estradiol—osteoporosis	0.000195	0.00224	CcSEcCtD
Telaprevir—Pruritus—Alendronate—osteoporosis	0.000194	0.00223	CcSEcCtD
Telaprevir—Eye disorder—Estradiol—osteoporosis	0.000194	0.00223	CcSEcCtD
Telaprevir—Asthenia—Ibandronate—osteoporosis	0.000192	0.0022	CcSEcCtD
Telaprevir—Nausea—Etidronic acid—osteoporosis	0.000192	0.0022	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000191	0.00219	CcSEcCtD
Telaprevir—Diarrhoea—Estropipate—osteoporosis	0.000191	0.00219	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Risedronate—osteoporosis	0.00019	0.00218	CcSEcCtD
Telaprevir—Infection—Zoledronate—osteoporosis	0.00019	0.00218	CcSEcCtD
Telaprevir—Fatigue—Risedronate—osteoporosis	0.00019	0.00218	CcSEcCtD
Telaprevir—Pruritus—Ibandronate—osteoporosis	0.000189	0.00217	CcSEcCtD
Telaprevir—Shock—Zoledronate—osteoporosis	0.000188	0.00216	CcSEcCtD
Telaprevir—Diarrhoea—Alendronate—osteoporosis	0.000188	0.00216	CcSEcCtD
Telaprevir—Asthenia—Calcitriol—osteoporosis	0.000188	0.00216	CcSEcCtD
Telaprevir—Nervous system disorder—Zoledronate—osteoporosis	0.000188	0.00215	CcSEcCtD
Telaprevir—Thrombocytopenia—Zoledronate—osteoporosis	0.000188	0.00215	CcSEcCtD
Telaprevir—Skin disorder—Zoledronate—osteoporosis	0.000186	0.00213	CcSEcCtD
Telaprevir—Pruritus—Calcitriol—osteoporosis	0.000185	0.00213	CcSEcCtD
Telaprevir—Diarrhoea—Raloxifene—osteoporosis	0.000185	0.00212	CcSEcCtD
Telaprevir—Dizziness—Estropipate—osteoporosis	0.000185	0.00212	CcSEcCtD
Telaprevir—Infection—Conjugated Estrogens—osteoporosis	0.000183	0.0021	CcSEcCtD
Telaprevir—Diarrhoea—Ibandronate—osteoporosis	0.000183	0.0021	CcSEcCtD
Telaprevir—Dizziness—Alendronate—osteoporosis	0.000182	0.00208	CcSEcCtD
Telaprevir—Shock—Conjugated Estrogens—osteoporosis	0.000181	0.00208	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000181	0.00208	CcSEcCtD
Telaprevir—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000181	0.00207	CcSEcCtD
Telaprevir—Malnutrition—Estradiol—osteoporosis	0.000181	0.00207	CcSEcCtD
Telaprevir—Fatigue—Pamidronate—osteoporosis	0.000181	0.00207	CcSEcCtD
Telaprevir—Urticaria—Ethinyl Estradiol—osteoporosis	0.00018	0.00206	CcSEcCtD
Telaprevir—Diarrhoea—Calcitriol—osteoporosis	0.000179	0.00206	CcSEcCtD
Telaprevir—Skin disorder—Conjugated Estrogens—osteoporosis	0.000179	0.00205	CcSEcCtD
Telaprevir—Dizziness—Raloxifene—osteoporosis	0.000179	0.00205	CcSEcCtD
Telaprevir—Vomiting—Estropipate—osteoporosis	0.000177	0.00203	CcSEcCtD
Telaprevir—ABCB1—bone marrow—osteoporosis	0.000177	0.00596	CbGeAlD
Telaprevir—Dysgeusia—Estradiol—osteoporosis	0.000177	0.00203	CcSEcCtD
Telaprevir—Dizziness—Ibandronate—osteoporosis	0.000177	0.00203	CcSEcCtD
Telaprevir—Rash—Estropipate—osteoporosis	0.000176	0.00202	CcSEcCtD
Telaprevir—Dermatitis—Estropipate—osteoporosis	0.000176	0.00202	CcSEcCtD
Telaprevir—Urticaria—Risedronate—osteoporosis	0.000175	0.00201	CcSEcCtD
Telaprevir—Vomiting—Alendronate—osteoporosis	0.000175	0.002	CcSEcCtD
Telaprevir—Rash—Alendronate—osteoporosis	0.000173	0.00199	CcSEcCtD
Telaprevir—Dermatitis—Alendronate—osteoporosis	0.000173	0.00199	CcSEcCtD
Telaprevir—Vomiting—Raloxifene—osteoporosis	0.000172	0.00197	CcSEcCtD
Telaprevir—Rash—Raloxifene—osteoporosis	0.00017	0.00195	CcSEcCtD
Telaprevir—Dermatitis—Raloxifene—osteoporosis	0.00017	0.00195	CcSEcCtD
Telaprevir—Vomiting—Ibandronate—osteoporosis	0.00017	0.00195	CcSEcCtD
Telaprevir—Rash—Ibandronate—osteoporosis	0.000169	0.00193	CcSEcCtD
Telaprevir—Dermatitis—Ibandronate—osteoporosis	0.000169	0.00193	CcSEcCtD
Telaprevir—Vomiting—Calcitriol—osteoporosis	0.000167	0.00191	CcSEcCtD
Telaprevir—Nausea—Estropipate—osteoporosis	0.000166	0.0019	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000165	0.0019	CcSEcCtD
Telaprevir—Rash—Calcitriol—osteoporosis	0.000165	0.00189	CcSEcCtD
Telaprevir—Fatigue—Zoledronate—osteoporosis	0.000165	0.00189	CcSEcCtD
Telaprevir—Dermatitis—Calcitriol—osteoporosis	0.000165	0.00189	CcSEcCtD
Telaprevir—Nausea—Alendronate—osteoporosis	0.000163	0.00187	CcSEcCtD
Telaprevir—Asthenia—Ethinyl Estradiol—osteoporosis	0.000162	0.00186	CcSEcCtD
Telaprevir—Syncope—Estradiol—osteoporosis	0.000162	0.00186	CcSEcCtD
Telaprevir—Nausea—Raloxifene—osteoporosis	0.000161	0.00184	CcSEcCtD
Telaprevir—Pruritus—Ethinyl Estradiol—osteoporosis	0.00016	0.00184	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000159	0.00183	CcSEcCtD
Telaprevir—Fatigue—Conjugated Estrogens—osteoporosis	0.000159	0.00182	CcSEcCtD
Telaprevir—Nausea—Ibandronate—osteoporosis	0.000159	0.00182	CcSEcCtD
Telaprevir—Loss of consciousness—Estradiol—osteoporosis	0.000159	0.00182	CcSEcCtD
Telaprevir—Asthenia—Risedronate—osteoporosis	0.000158	0.00181	CcSEcCtD
Telaprevir—Pruritus—Risedronate—osteoporosis	0.000156	0.00179	CcSEcCtD
Telaprevir—Nausea—Calcitriol—osteoporosis	0.000156	0.00178	CcSEcCtD
Telaprevir—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000155	0.00177	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000153	0.00175	CcSEcCtD
Telaprevir—Urticaria—Zoledronate—osteoporosis	0.000152	0.00174	CcSEcCtD
Telaprevir—Diarrhoea—Risedronate—osteoporosis	0.000151	0.00173	CcSEcCtD
Telaprevir—Asthenia—Pamidronate—osteoporosis	0.00015	0.00172	CcSEcCtD
Telaprevir—Dizziness—Ethinyl Estradiol—osteoporosis	0.00015	0.00172	CcSEcCtD
Telaprevir—Pruritus—Pamidronate—osteoporosis	0.000148	0.0017	CcSEcCtD
Telaprevir—Infection—Estradiol—osteoporosis	0.000147	0.00168	CcSEcCtD
Telaprevir—Urticaria—Conjugated Estrogens—osteoporosis	0.000146	0.00168	CcSEcCtD
Telaprevir—Dizziness—Risedronate—osteoporosis	0.000146	0.00167	CcSEcCtD
Telaprevir—Shock—Estradiol—osteoporosis	0.000145	0.00166	CcSEcCtD
Telaprevir—Nervous system disorder—Estradiol—osteoporosis	0.000145	0.00166	CcSEcCtD
Telaprevir—Vomiting—Ethinyl Estradiol—osteoporosis	0.000144	0.00165	CcSEcCtD
Telaprevir—Diarrhoea—Pamidronate—osteoporosis	0.000143	0.00164	CcSEcCtD
Telaprevir—Skin disorder—Estradiol—osteoporosis	0.000143	0.00164	CcSEcCtD
Telaprevir—Rash—Ethinyl Estradiol—osteoporosis	0.000143	0.00164	CcSEcCtD
Telaprevir—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000143	0.00163	CcSEcCtD
Telaprevir—Vomiting—Risedronate—osteoporosis	0.00014	0.00161	CcSEcCtD
Telaprevir—Rash—Risedronate—osteoporosis	0.000139	0.00159	CcSEcCtD
Telaprevir—Dermatitis—Risedronate—osteoporosis	0.000139	0.00159	CcSEcCtD
Telaprevir—Dizziness—Pamidronate—osteoporosis	0.000139	0.00159	CcSEcCtD
Telaprevir—Asthenia—Zoledronate—osteoporosis	0.000137	0.00158	CcSEcCtD
Telaprevir—Pruritus—Zoledronate—osteoporosis	0.000135	0.00155	CcSEcCtD
Telaprevir—Nausea—Ethinyl Estradiol—osteoporosis	0.000134	0.00154	CcSEcCtD
Telaprevir—Vomiting—Pamidronate—osteoporosis	0.000133	0.00153	CcSEcCtD
Telaprevir—Asthenia—Conjugated Estrogens—osteoporosis	0.000132	0.00152	CcSEcCtD
Telaprevir—Rash—Pamidronate—osteoporosis	0.000132	0.00152	CcSEcCtD
Telaprevir—Dermatitis—Pamidronate—osteoporosis	0.000132	0.00151	CcSEcCtD
Telaprevir—Diarrhoea—Zoledronate—osteoporosis	0.000131	0.0015	CcSEcCtD
Telaprevir—Nausea—Risedronate—osteoporosis	0.000131	0.0015	CcSEcCtD
Telaprevir—Pruritus—Conjugated Estrogens—osteoporosis	0.00013	0.0015	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Estradiol—osteoporosis	0.000127	0.00146	CcSEcCtD
Telaprevir—Fatigue—Estradiol—osteoporosis	0.000127	0.00146	CcSEcCtD
Telaprevir—Dizziness—Zoledronate—osteoporosis	0.000127	0.00145	CcSEcCtD
Telaprevir—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000126	0.00145	CcSEcCtD
Telaprevir—Nausea—Pamidronate—osteoporosis	0.000125	0.00143	CcSEcCtD
Telaprevir—Dizziness—Conjugated Estrogens—osteoporosis	0.000122	0.0014	CcSEcCtD
Telaprevir—Vomiting—Zoledronate—osteoporosis	0.000122	0.0014	CcSEcCtD
Telaprevir—Rash—Zoledronate—osteoporosis	0.000121	0.00138	CcSEcCtD
Telaprevir—Dermatitis—Zoledronate—osteoporosis	0.000121	0.00138	CcSEcCtD
Telaprevir—Vomiting—Conjugated Estrogens—osteoporosis	0.000117	0.00134	CcSEcCtD
Telaprevir—Urticaria—Estradiol—osteoporosis	0.000117	0.00134	CcSEcCtD
Telaprevir—Rash—Conjugated Estrogens—osteoporosis	0.000116	0.00133	CcSEcCtD
Telaprevir—Dermatitis—Conjugated Estrogens—osteoporosis	0.000116	0.00133	CcSEcCtD
Telaprevir—Nausea—Zoledronate—osteoporosis	0.000114	0.0013	CcSEcCtD
Telaprevir—Nausea—Conjugated Estrogens—osteoporosis	0.00011	0.00126	CcSEcCtD
Telaprevir—ALB—Platelet degranulation—FGA—osteoporosis	0.000108	0.00144	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—KL—osteoporosis	0.000107	0.00142	CbGpPWpGaD
Telaprevir—Asthenia—Estradiol—osteoporosis	0.000106	0.00121	CcSEcCtD
Telaprevir—Pruritus—Estradiol—osteoporosis	0.000104	0.0012	CcSEcCtD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000103	0.00137	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MGLL—osteoporosis	0.000103	0.00137	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—KL—osteoporosis	0.000103	0.00136	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000103	0.00136	CbGpPWpGaD
Telaprevir—Diarrhoea—Estradiol—osteoporosis	0.000101	0.00116	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—LRP5—osteoporosis	0.000101	0.00134	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PSMA2—osteoporosis	9.99e-05	0.00133	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PSMA5—osteoporosis	9.99e-05	0.00133	CbGpPWpGaD
Telaprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	9.98e-05	0.00133	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IRAK3—osteoporosis	9.96e-05	0.00132	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	9.87e-05	0.00131	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—FGB—osteoporosis	9.85e-05	0.00131	CbGpPWpGaD
Telaprevir—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	9.85e-05	0.00131	CbGpPWpGaD
Telaprevir—Dizziness—Estradiol—osteoporosis	9.76e-05	0.00112	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—LRP6—osteoporosis	9.63e-05	0.00128	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	9.44e-05	0.00125	CbGpPWpGaD
Telaprevir—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	9.41e-05	0.00125	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	9.39e-05	0.00125	CbGpPWpGaD
Telaprevir—Vomiting—Estradiol—osteoporosis	9.38e-05	0.00108	CcSEcCtD
Telaprevir—Rash—Estradiol—osteoporosis	9.31e-05	0.00107	CcSEcCtD
Telaprevir—Dermatitis—Estradiol—osteoporosis	9.3e-05	0.00107	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—IL6—osteoporosis	9.28e-05	0.00123	CbGpPWpGaD
Telaprevir—CTSK—Immune System—RAP1A—osteoporosis	9.24e-05	0.00123	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ACTG1—osteoporosis	9.11e-05	0.00121	CbGpPWpGaD
Telaprevir—CTSK—Immune System—NFATC1—osteoporosis	9.02e-05	0.0012	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—KL—osteoporosis	8.81e-05	0.00117	CbGpPWpGaD
Telaprevir—Nausea—Estradiol—osteoporosis	8.77e-05	0.00101	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—KL—osteoporosis	8.46e-05	0.00112	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—AGER—osteoporosis	8.41e-05	0.00112	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—ADCY5—osteoporosis	8.38e-05	0.00111	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	8.31e-05	0.0011	CbGpPWpGaD
Telaprevir—CTSK—Toll-Like Receptors Cascades—IL6—osteoporosis	8.27e-05	0.0011	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	8.15e-05	0.00108	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TLN1—osteoporosis	8.13e-05	0.00108	CbGpPWpGaD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	8.09e-05	0.00107	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—SOD2—osteoporosis	7.68e-05	0.00102	CbGpPWpGaD
Telaprevir—CTSS—Immune System—RAP1A—osteoporosis	7.61e-05	0.00101	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CTSK—osteoporosis	7.55e-05	0.001	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	7.46e-05	0.00099	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—TGFB1—osteoporosis	7.45e-05	0.000989	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NFATC1—osteoporosis	7.42e-05	0.000986	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PSMA2—osteoporosis	7.36e-05	0.000977	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PSMA5—osteoporosis	7.36e-05	0.000977	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—IRS2—osteoporosis	7.33e-05	0.000973	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—GPX1—osteoporosis	7.33e-05	0.000973	CbGpPWpGaD
Telaprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	7.22e-05	0.000959	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—IRS2—osteoporosis	7.04e-05	0.000934	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—LEP—osteoporosis	7.03e-05	0.000934	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—P4HB—osteoporosis	7.01e-05	0.000931	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—AGER—osteoporosis	6.92e-05	0.000919	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—ADCY5—osteoporosis	6.9e-05	0.000916	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PTH—osteoporosis	6.82e-05	0.000906	CbGpPWpGaD
Telaprevir—CTSS—Toll-Like Receptors Cascades—IL6—osteoporosis	6.81e-05	0.000904	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—MTHFR—osteoporosis	6.76e-05	0.000898	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—RAP1A—osteoporosis	6.7e-05	0.00089	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—WDR1—osteoporosis	6.69e-05	0.000888	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CNR2—osteoporosis	6.65e-05	0.000883	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—TGFB1—osteoporosis	6.64e-05	0.000882	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NFATC1—osteoporosis	6.54e-05	0.000868	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—DKK1—osteoporosis	6.49e-05	0.000861	CbGpPWpGaD
Telaprevir—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	6.49e-05	0.000861	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	6.43e-05	0.000853	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—IRS1—osteoporosis	6.4e-05	0.00085	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	6.34e-05	0.000842	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—WNT1—osteoporosis	6.25e-05	0.00083	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KL—osteoporosis	6.23e-05	0.000827	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—IRS1—osteoporosis	6.15e-05	0.000816	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	6.1e-05	0.00081	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGA—osteoporosis	6.08e-05	0.000807	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PSMA5—osteoporosis	6.06e-05	0.000805	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PSMA2—osteoporosis	6.06e-05	0.000805	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—POMC—osteoporosis	6.04e-05	0.000802	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—IRS2—osteoporosis	6.04e-05	0.000801	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—IL6R—osteoporosis	6.01e-05	0.000798	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	5.82e-05	0.000773	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—IGF1—osteoporosis	5.81e-05	0.000771	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—IRS2—osteoporosis	5.8e-05	0.00077	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PTHLH—osteoporosis	5.65e-05	0.00075	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—BMP2—osteoporosis	5.65e-05	0.00075	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGB—osteoporosis	5.53e-05	0.000734	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	5.52e-05	0.000732	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—TGFB1—osteoporosis	5.47e-05	0.000726	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	5.37e-05	0.000713	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PSMA5—osteoporosis	5.34e-05	0.000709	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PSMA2—osteoporosis	5.34e-05	0.000709	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	5.32e-05	0.000707	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	5.3e-05	0.000703	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CAP1—osteoporosis	5.29e-05	0.000702	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—IRS1—osteoporosis	5.27e-05	0.0007	CbGpPWpGaD
Telaprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.24e-05	0.000696	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	5.22e-05	0.000692	CbGpPWpGaD
Telaprevir—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.18e-05	0.000687	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KL—osteoporosis	5.13e-05	0.000681	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—IRS1—osteoporosis	5.06e-05	0.000672	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.05e-05	0.00067	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CALCA—osteoporosis	4.98e-05	0.000661	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—IL6R—osteoporosis	4.95e-05	0.000657	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	4.93e-05	0.000655	CbGpPWpGaD
Telaprevir—CTSK—Immune System—AGER—osteoporosis	4.9e-05	0.00065	CbGpPWpGaD
Telaprevir—CTSK—Immune System—ADCY5—osteoporosis	4.88e-05	0.000648	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	4.8e-05	0.000638	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KL—osteoporosis	4.52e-05	0.0006	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—IGF1—osteoporosis	4.46e-05	0.000592	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	4.37e-05	0.00058	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	4.3e-05	0.000571	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IRS2—osteoporosis	4.27e-05	0.000567	CbGpPWpGaD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.25e-05	0.000564	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	4.25e-05	0.000564	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	4.24e-05	0.000563	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MGLL—osteoporosis	4.2e-05	0.000558	CbGpPWpGaD
Telaprevir—CTSS—Immune System—AGER—osteoporosis	4.03e-05	0.000535	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ADCY5—osteoporosis	4.02e-05	0.000533	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IL1B—osteoporosis	4.01e-05	0.000533	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.93e-05	0.000521	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PLEK—osteoporosis	3.84e-05	0.00051	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ANXA2—osteoporosis	3.84e-05	0.00051	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.83e-05	0.000508	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IRS1—osteoporosis	3.73e-05	0.000495	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	3.71e-05	0.000493	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	3.58e-05	0.000475	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ADCY5—osteoporosis	3.54e-05	0.00047	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IRS2—osteoporosis	3.52e-05	0.000467	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL6R—osteoporosis	3.5e-05	0.000465	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	3.48e-05	0.000462	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SPP1—osteoporosis	3.42e-05	0.000455	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.33e-05	0.000442	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TLN1—osteoporosis	3.31e-05	0.00044	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VCL—osteoporosis	3.27e-05	0.000434	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	3.19e-05	0.000423	CbGpPWpGaD
Telaprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.15e-05	0.000418	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IRS2—osteoporosis	3.1e-05	0.000411	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IRS1—osteoporosis	3.07e-05	0.000407	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.06e-05	0.000406	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL1B—osteoporosis	3.05e-05	0.000404	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—LEP—osteoporosis	3.03e-05	0.000402	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.91e-05	0.000387	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TNF—osteoporosis	2.91e-05	0.000387	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ESR1—osteoporosis	2.89e-05	0.000384	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	2.89e-05	0.000384	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL6R—osteoporosis	2.88e-05	0.000383	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—RAP1A—osteoporosis	2.73e-05	0.000362	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IRS1—osteoporosis	2.7e-05	0.000359	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—IL6—osteoporosis	2.68e-05	0.000356	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—TGFB1—osteoporosis	2.67e-05	0.000355	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL1B—osteoporosis	2.66e-05	0.000354	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—POMC—osteoporosis	2.6e-05	0.000346	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.6e-05	0.000345	CbGpPWpGaD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.55e-05	0.000339	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	2.55e-05	0.000338	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL6R—osteoporosis	2.54e-05	0.000337	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IGF1—osteoporosis	2.5e-05	0.000332	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—FGA—osteoporosis	2.48e-05	0.000329	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PKM—osteoporosis	2.37e-05	0.000315	CbGpPWpGaD
Telaprevir—ALB—Metabolism—FDPS—osteoporosis	2.37e-05	0.000315	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TGFB1—osteoporosis	2.37e-05	0.000314	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IL6—osteoporosis	2.35e-05	0.000312	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—TNF—osteoporosis	2.31e-05	0.000307	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.26e-05	0.0003	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—FGB—osteoporosis	2.25e-05	0.000299	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	2.25e-05	0.000299	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GPD2—osteoporosis	2.25e-05	0.000298	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PGLS—osteoporosis	2.25e-05	0.000298	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.23e-05	0.000296	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TNF—osteoporosis	2.21e-05	0.000293	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—IL6—osteoporosis	2.21e-05	0.000293	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL1B—osteoporosis	2.19e-05	0.000291	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PKM—osteoporosis	2.08e-05	0.000276	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—FDPS—osteoporosis	2.08e-05	0.000276	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ATIC—osteoporosis	2.06e-05	0.000273	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PNP—osteoporosis	2.06e-05	0.000273	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	1.98e-05	0.000263	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PGLS—osteoporosis	1.97e-05	0.000261	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GPD2—osteoporosis	1.97e-05	0.000261	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.95e-05	0.000259	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—IL6—osteoporosis	1.87e-05	0.000248	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PNP—osteoporosis	1.8e-05	0.000239	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ATIC—osteoporosis	1.8e-05	0.000239	CbGpPWpGaD
Telaprevir—ALB—Metabolism—OXCT1—osteoporosis	1.75e-05	0.000232	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CA2—osteoporosis	1.75e-05	0.000232	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MGLL—osteoporosis	1.7e-05	0.000226	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.61e-05	0.000213	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL6—osteoporosis	1.56e-05	0.000207	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—OXCT1—osteoporosis	1.53e-05	0.000203	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CA2—osteoporosis	1.53e-05	0.000203	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—osteoporosis	1.51e-05	0.0002	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TGFB1—osteoporosis	1.5e-05	0.000199	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MGLL—osteoporosis	1.49e-05	0.000198	CbGpPWpGaD
Telaprevir—ALB—Metabolism—IDH2—osteoporosis	1.45e-05	0.000192	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP27A1—osteoporosis	1.36e-05	0.000181	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—POMC—osteoporosis	1.36e-05	0.00018	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ACP5—osteoporosis	1.32e-05	0.000176	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.31e-05	0.000174	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL6—osteoporosis	1.28e-05	0.000171	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PKM—osteoporosis	1.28e-05	0.00017	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—FDPS—osteoporosis	1.28e-05	0.00017	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—IDH2—osteoporosis	1.27e-05	0.000168	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.25e-05	0.000166	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TPI1—osteoporosis	1.23e-05	0.000163	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GPD2—osteoporosis	1.21e-05	0.000161	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PGLS—osteoporosis	1.21e-05	0.000161	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP27A1—osteoporosis	1.19e-05	0.000158	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.19e-05	0.000157	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.17e-05	0.000155	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.17e-05	0.000155	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ACP5—osteoporosis	1.16e-05	0.000154	CbGpPWpGaD
Telaprevir—ALB—Metabolism—P4HB—osteoporosis	1.16e-05	0.000154	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GAPDH—osteoporosis	1.14e-05	0.000151	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL6—osteoporosis	1.13e-05	0.00015	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PNP—osteoporosis	1.11e-05	0.000147	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ATIC—osteoporosis	1.11e-05	0.000147	CbGpPWpGaD
Telaprevir—ALB—Metabolism—RAP1A—osteoporosis	1.11e-05	0.000147	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.09e-05	0.000145	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.09e-05	0.000145	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TPI1—osteoporosis	1.08e-05	0.000143	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IGF1—osteoporosis	1.02e-05	0.000135	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—P4HB—osteoporosis	1.01e-05	0.000135	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GAPDH—osteoporosis	9.96e-06	0.000132	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—RAP1A—osteoporosis	9.7e-06	0.000129	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.65e-06	0.000128	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CA2—osteoporosis	9.44e-06	0.000125	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—OXCT1—osteoporosis	9.44e-06	0.000125	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MGLL—osteoporosis	9.2e-06	0.000122	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ENO1—osteoporosis	8.95e-06	0.000119	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PSMA2—osteoporosis	8.82e-06	0.000117	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PSMA5—osteoporosis	8.82e-06	0.000117	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ENO1—osteoporosis	7.84e-06	0.000104	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—IDH2—osteoporosis	7.82e-06	0.000104	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PSMA2—osteoporosis	7.73e-06	0.000103	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PSMA5—osteoporosis	7.73e-06	0.000103	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP27A1—osteoporosis	7.35e-06	9.76e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP19A1—osteoporosis	7.15e-06	9.5e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ACP5—osteoporosis	7.15e-06	9.49e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TPI1—osteoporosis	6.65e-06	8.83e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP19A1—osteoporosis	6.27e-06	8.32e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—P4HB—osteoporosis	6.25e-06	8.3e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GAPDH—osteoporosis	6.14e-06	8.15e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TGFB1—osteoporosis	6.11e-06	8.12e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—RAP1A—osteoporosis	5.98e-06	7.93e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ADCY5—osteoporosis	5.85e-06	7.76e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GPX1—osteoporosis	5.83e-06	7.73e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTHFR—osteoporosis	5.38e-06	7.14e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ADCY5—osteoporosis	5.12e-06	6.8e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GPX1—osteoporosis	5.1e-06	6.78e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ENO1—osteoporosis	4.83e-06	6.41e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PSMA5—osteoporosis	4.76e-06	6.32e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PSMA2—osteoporosis	4.76e-06	6.32e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTHFR—osteoporosis	4.71e-06	6.25e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—POMC—osteoporosis	4.3e-06	5.71e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.86e-06	5.13e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—POMC—osteoporosis	3.77e-06	5e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ADCY5—osteoporosis	3.16e-06	4.19e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GPX1—osteoporosis	3.14e-06	4.17e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTHFR—osteoporosis	2.9e-06	3.85e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—POMC—osteoporosis	2.32e-06	3.08e-05	CbGpPWpGaD
